Clinical responses following nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma are associated with expansion of CD8+ IFN-gamma-producing T cells.

Item

http://www.wikidata.org/entity/Q43850963

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Clinical responses following n ...... + IFN-gamma-producing T cells.

@en

Clinical responses following n ...... + IFN-gamma-producing T cells.

@nl

type

Item

label

Clinical responses following n ...... + IFN-gamma-producing T cells.

@en

Clinical responses following n ...... + IFN-gamma-producing T cells.

@nl

prefLabel

Clinical responses following n ...... + IFN-gamma-producing T cells.

@en

Clinical responses following n ...... + IFN-gamma-producing T cells.

@nl

P1476

Clinical responses following n ...... + IFN-gamma-producing T cells.

@en

P2093

Artz AS

http://www.w3.org/2001/XMLSchema#string

Gajewski TF

http://www.w3.org/2001/XMLSchema#string

Harlin H

http://www.w3.org/2001/XMLSchema#string

Mahowald M

http://www.w3.org/2001/XMLSchema#string

Rini BI

http://www.w3.org/2001/XMLSchema#string

Vogelzang NJ

http://www.w3.org/2001/XMLSchema#string

Zimmerman T

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

Minor histocompatibility antigens--targets of graft versus leukemia responses.

Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines.

Randomized study of interleukin 2 (IL-2) alone vs IL-2 plus lymphokine-activated killer cells for treatment of melanoma and renal cell cancer.

Response differences between human CD4(+) and CD8(+) T-cells during CD28 costimulation: implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging.

Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results.

Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer.

P2888

sj.bmt.1704385

P304

491-497

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BMT.1704385

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8925351

http://www.w3.org/2001/XMLSchema#string

P6179

1023621305

http://www.w3.org/2001/XMLSchema#string

P698

14716341

http://www.w3.org/2001/XMLSchema#string